What other cannabis stocks are there to watch? MGC Pharmaceuticals Ltd (LSE) also recently floated on the LSE and its share price has also soared from a float value of 2.38p to highs of 7.43p. The Australian-headquartered company developed medicinal cannabis treatments focused on treating Covid-19 patients, as well as individuals affected by epilepsy and Alzheimer’s disease.
Could Kanabo Group shares soar if UK medical cannabis sector matures? Kanabo Group shares rocketed upon entry to the stock market, rising from an issue price of 6.5p to 20.8p per share on the opening day. Will the rise of specialist medical cannabis clinics benefit Kanabo Group investors?
Apollon Formularies - Our strategy is to become the premiere global medical cannabis company legally licensed to develop successful personalised clinical treatments utilizing artificial intelligence on patient data.
"I'm very lucky to be married to a wonderful man who is a plant medicine man, and he has great knowledge," she said. "Now he's growing medicinal cannabis for me, and it just has been wonderful. It helps me in every area."